Zydus Oncology
Zydus Oncology, a division of Zydus Cadila, is a prominent player in the oncology pharmaceutical sector, headquartered in India. Established in 1995, the company has made significant strides in developing innovative cancer therapies, focusing on both generic and proprietary formulations. With a strong presence in major operational regions across Asia, Europe, and the Americas, Zydus Oncology is committed to enhancing patient outcomes through advanced treatment options. The company’s core offerings include a diverse range of oncology products, such as targeted therapies and biosimilars, distinguished by their quality and affordability. Zydus Oncology has achieved notable milestones, including the launch of several first-in-class therapies, solidifying its position as a leader in the oncology market. With a dedication to research and development, Zydus Oncology continues to push the boundaries of cancer treatment, striving to make a meaningful impact in the lives of patients worldwide.
DitchCarbon Score
How does Zydus Oncology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zydus Oncology's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zydus Oncology's reported carbon emissions
Zydus Oncology, headquartered in India, currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their climate impact or commitments. However, the company may be engaged in broader industry initiatives aimed at reducing carbon footprints and enhancing sustainability practices. As the pharmaceutical sector increasingly focuses on climate action, Zydus Oncology's future commitments and strategies will be crucial in aligning with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zydus Oncology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
